Verdict is still out. There are some positives so far that I can see. But, as expected, drastic changes versus being in small Pharma (although some legacy Biohave might have said we were always “big Pharma” but I don’t agree. The regulations and compliance is right back to where I was prior to Biohaven and feels robotic again. No more autonomy to truly go out and sell. And don’t tell me we weren’t selling-I sold my butt off launching this drug and it was refreshing for once in Pharma. And made a lot of money doing it). It was nice having a little more freedom in terms of being able to run our business and that’s one reason we were so incredibly successful. Concerned about the compensation, particularly bonus. Not loving have the vaccine/COVID stuff pushed on us and having to do so with our Doctors. I’m not an anti-vaxxer, but I think we all know now it’s not the silver bullet and has some issues/concerns and I’m not necessarily comfortable with how the company is continuing to profit from it. Flip side, possibly more career opportunities and I think they can elevate our drug to a much more widely visible and available product. Only time will tell and I think most that I’ve talked to feel pretty similar and are giving it some time to see how it goes and a fair shot.